EUA atacam Irã após derrubada de helicóptero militar Ivar AI

The Times of India

Citi leverages AI to transform payments, boost efficiency and enhance cross-border transactions

Yahoo Entertainment

美股屠殺外溢亞股，KOSPI早盤狂瀉8.37%，三星、SK海力士遭血洗

GlobeNewswire

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

CBS News

U.S. launches more strikes on Iranian targets after Trump promises to hit Iran "hard"

N-tv.de

Nach Hubschrauber-Abschuss: "Selbstverteidigung": US-Militär fliegt neue Angriffe gegen den Iran

Diariobitcoin.com

Binance Research: el mercado de activos tokenizados creció un 589% en apenas un año

Crypto Briefing

Cynthia Lummis calls for US to accumulate Bitcoin openly while other nations buy quietly

PBS

U.S. launches new strikes in Iran after missiles target American bases

BusinessLine

US inflation climbs to 4.2% and hits 3-year high amid rising fuel costs

Noticiabrasil.net.br

A nova fronteira do agro: como o Brasil pode liderar IA para agricultura?

Crypto Briefing

US Central Command intercepts Iranian missiles, strikes radar sites in Strait of Hormuz escalation

DW (English)

EE.UU. lanza ataques contra Irán en represalia por derribo de helicóptero

Digitimes

AI demand is turning memory chips into rationed assets, Morgan Stanley says

The Times of India

'The Donald of Dubai': UAE billionaire close to Trump bets $66 billion on AI to become the world's data king

Crypto Briefing

NYSE reports 50% revenue growth and 10x increase in free cash flow

The Times of India

Why is the US stock market crashing today? S&P 500 erases all gains and wipes out $1.3 trillion in 2 hours as Nasdaq and Dow turn sharply lower - Tech stocks and chip sector collapse

Nacion.com

Estados Unidos vuelve a bombardear Irán en respuesta al derribo de un helicóptero

Diariobitcoin.com

Zcash vuela un 23% en un solo día: ¿inicio de una nueva era para la privacidad en cripto?

Yahoo Entertainment

幫馬斯克撈火箭！27歲的她有望變億萬富豪　靠「1大膽決定」迎SpaceX上市

$Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire$

GlobeNewswire

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire